Rockley Photonics Holdings Limited (RKLY)
| Previous close | 2.9500 |
| Open | 3.2300 |
| Bid | 2.9500 x 1100 |
| Ask | 2.9700 x 900 |
| Day's range | 2.9320 - 3.2900 |
| 52-week range | 2.8100 - 16.9900 |
| Volume | |
| Avg. volume | 747,758 |
| Market cap | 380.594M |
| Beta (5Y monthly) | -0.26 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.4730 |
| Earnings date | 15 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 16.20 |
- Business Wire
Rockley Photonics Reaches Key Milestone in the Development of Cuffless, Non-Invasive Blood Pressure Measurement on the Wrist, Potentially Enabling a New Measurement Technique for Cardiovascular Health
OXFORD, England & PASADENA, Calif., January 20, 2022--Rockley Photonics Holdings Limited (NYSE: RKLY) ("Rockley"), a global leader in photonics-based health monitoring and communications solutions, today announced that the company has successfully completed the first stage of its human studies examining the measurement of blood pressure using Rockley’s biomarker sensing platform.
- Business Wire
Rockley Photonics to Present at 24th Annual Needham Virtual Growth Conference
OXFORD, England & PASADENA, Calif., January 04, 2022--Rockley Photonics to Present at 24th Annual Needham Virtual Growth Conference
- Business Wire
Rockley Photonics Provides Business Update Following the U.S. Bureau of Industry and Security Action Relating to Its Joint Venture Partner
OXFORD, England & PASADENA, Calif., December 21, 2021--Rockley Photonics (NYSE: RKLY) ("the Company" or "Rockley"), a global leader in photonics-based health monitoring and communications solutions, today announced its intention not to proceed, under current circumstances, with its data-communications-related technical sale to Hengtong Rockley Technology Co. Ltd., its joint venture ("the JV") with Jiangsu Hengtong Optic-Electric Co., Ltd. ("Hengtong"). As a result, Rockley issued an updated busi
